Nitroglycerin

Overview

Nitroglycerin is a nitrate vasodilator that dilates blood vessels, improving blood flow and reducing heart workload. It is commonly used for the treatment and prevention of angina pectoris.

API suppliers (6)

Suppliers of Nitroglycerin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• COPPERHEAD INVESTMENTS INC1 active DMF
• DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK1 active DMF
• COPPERHEAD INVESTMENTS INC1 active DMF
• DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK1 active DMF
• COPPERHEAD INVESTMENTS INC1 active DMF
• VICTOR M HERMELIN CO DIV K-V PHARMACAL CO

Patent & exclusivity (US)

Per the FDA Orange Book (51 approved US products), the latest listed US patent on Nitroglycerin expires 12 Mar 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

2-[bis(2-hydroxyethyl)amino]ethanol

Canonical SMILES

C(CO)N(CCO)CCO

InChIKey

GSEJCLTVZPLZKY-UHFFFAOYSA-N

Therapeutic areas